APA (7th ed.) Citation

Solh, M. M., Hinojosa, G., Laporte, J., Solomon, S. R., Morris, L. E., Zhang, X., . . . Bashey, A. A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies. Wiley.

Chicago Style (17th ed.) Citation

Solh, Melhem M., Gabriel Hinojosa, Justin Laporte, Scott R. Solomon, Lawrence E. Morris, Xu Zhang, H. Kent Holland, and Asad Bashey. A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies. Wiley.

MLA (9th ed.) Citation

Solh, Melhem M., et al. A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies. Wiley.